Executive Director, Neurology Key Accounts

Regeneron is seeking an Executive Director, Neurology Key Accounts to join our organization!

In this role, a typical day might include:

The Executive Director, Neurology Key Accounts is a senior leadership role responsible for building, leading, and scaling a team of 8 Neurology Account Directors (NADs) supporting the launch and commercialization of Regeneron's C5 inhibitor for generalized myasthenia gravis (gMG). This leader will establish the institutional neurology accounts team targeting approximately 75 - 100 academic medical centers (AMCs) and neuromuscular specialty centers.

The Executive Director will serve as the senior commercial interface between Market Access, Commercial Sales, Medical Affairs, and Patient Services to ensure formulary access, competitive access execution, and seamless patient transitions within targeted institutions. This role requires a rare combination of strategic vision, people leadership, institutional account management expertise, and deep understanding of rare disease and neurology market dynamics.

This role might be for you if can: ​

Team Leadership & Development

• Recruit, hire, onboard, and develop a team of 8 high-performing Neurology Account Directors with rare disease or neurology institutional backgrounds.

• Establish performance expectations, KPIs, coaching cadence, and talent development plans aligned to launch milestones and franchise growth objectives.

• Foster a high-accountability, patient-centered team culture grounded in clinical credibility, institutional depth, and cross-functional collaboration.

• Conduct regular field rides, account planning supervision, joint account calls, and performance reviews; model the institutional account management behaviors expected of the NAD team.

Strategy & Account Planning

• Contribute and lead the national institutional neurology accounts team for the C5 inhibitor launch, including account tiering, territory alignment, and coverage optimization across 8 U.S. regions.

• Build the competitive account management playbook targeting approximately 3,500 Ultomiris-treated gMG patients concentrated at major AMC and neuromuscular centers.

• Develop and evolve account engagement models encompassing formulary strategy, P&T committee navigation, infusion pull-through, and patient services coordination. 

Cross-Functional Leadership

• Serve as the primary Market Access liaison to Neurology Commercial Sales leadership, ensuring alignment on account coverage, messaging, and institutional pull-through.

• Collaborate with Market Access field teams (National Account Directors, Payer Account Directors) on institutional contracting strategy, payer policy coordination, and prior authorization barrier resolution.

• Partner with Medical Affairs on KOL strategy, congress engagement, and medical education programming aligned to institutional account plans.

• Coordinate with Patient Services leadership on hub services, specialty pharmacy workflows, and reimbursement case resolution for targeted institutions.

Performance Management & Analytics

• Define and track KPIs

• Prepare and present quarterly business reviews to VP and senior leadership, synthesizing account progress, market dynamics, competitive intelligence, and investment recommendations.

• Serve as budget owner for the Neurology Key Accounts team including headcount, operating expenses, and congress/education investments.

To be considered for this opportunity, you must have the following:

• Bachelor's degree required; advanced degree (MBA, PharmD, PhD) strongly preferred.

• Minimum 12+ years pharmaceutical/biotech experience with at least 5 years leading institutional account, market access, patient services, or other account management teams.

• Proven track record building and scaling high-performing field account teams, ideally in rare disease, neurology, or specialty biologic environments.

• Deep institutional account management expertise including AMC/IDN formulary strategy, P&T committee engagement, and buy-and-bill economics.

• Strong strategic planning and analytics capabilities with experience leveraging claims data, commercial intelligence, and market research.

• Exceptional cross-functional leadership skills with demonstrated ability to influence across Sales, Medical Affairs, Patient Services, and Payer functions.

• Excellent executive communication and presentation skills with experience presenting to senior leadership and external stakeholders.

Preferred

• Launch leadership experience in rare disease, neurology, or specialty biologic markets.

• Direct experience with infusion biologics, complement inhibitors, or autoimmune neurology therapies, or other highly complex advanced therapeutics.

• Existing relationships with academic neurology leadership, MGFA-recognized centers, or neuromuscular KOL community.

• Understanding of myasthenia gravis disease management, treatment landscape, and patient journey.

CORE COMPETENCIES

• Strategic Leadership – Translates franchise objectives into executable institutional account strategies with measurable KPIs and clear accountability frameworks.

• Team Development – Builds and retains top talent through coaching, mentorship, career pathing, and performance-based recognition.

• Cross-Functional Collaboration – Orchestrates complex, matrixed partnerships across Commercial, Medical, Payer, and Patient Services with shared accountability for outcomes.

• Clinical Credibility – Commands respect with clinical and medical stakeholders based on deep therapeutic knowledge and the ability to translate science into commercial impact.

• Results Orientation – Drives accountability through data, KPIs, and a relentless focus on formulary wins, patient switches, and revenue growth.

• Executive Communication – Synthesizes complex market and account dynamics into clear, compelling narratives for senior leadership.

$255,000.00 - $424,900.00